|
Exclusivity Start Date
|
Generic Name
|
Trade Name
|
Indication for Original Approval
|
|
10/17/85
|
Somatropin
|
Nutropin
|
For use in the long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion
|
|
10/17/85
|
Somatrem for injection
|
Protropin
|
For long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion
|
|
3/8/87
|
Somatropin for injection
|
Humatrope
|
For the long-term treatment of children who have growth failure due to inadequate secretion of normal endogenous growth hormone
|
|
8/2/90
|
Colfosceril palmitate, cetyl alcohol, tyloxapol
|
Exosurf neonatal for intratracheal suspension
|
Treatment of established hyaline membrane disease at all gestational ages
|
|
1/30/91
|
Succimer
|
Chemet capsules
|
Treatment of lead poisoning in children
|
|
7/1/91
|
Beractant
|
Survanta intratracheal suspension
|
(1) Prevention of RDS (hyaline membrane disease) in premature infants less than 1250 grams birth weight or with evidence of surfactant deficiency. (2) Treatment of (“rescue”) premature infants with RDS confirmed by x-ray and requiring mechanical ventilation.
|
|
12/24/91
|
Histrelin acetate
|
Supprelin injection
|
Treatment of central precocious puberty
|
|
2/26/92
|
Nafarelin acetate
|
Synarel nasal solution
|
Treatment of central precocious puberty
|
|
7/14/92
|
Teniposide
|
Vumon for injection
|
Induction therapy in patients with refractory childhood acute lymphoblastic leukemia
|
|
4/16/93
|
Leuprolide acetate
|
Lupron injection
|
Treatment of children with central precocious puberty
|
|
7/29/93
|
Felbamate
|
Felbatol
|
As adjunctive therapy in the treatment of partial and generalized seizures associated with the Lennox-Gastaut syndrome in children
|
|
12/27/93
|
Immune globulin intravenous, human
|
Gamimune N
|
Infection prophylaxis in pediatric patients affected with the human immunodeficiency virus
|